Revvity Debt to Equity Ratio 2012-2026 | RVTY
Current and historical debt to equity ratio values for Revvity (RVTY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Revvity debt/equity for the three months ending March 31, 2026 was 0.36.
| Revvity Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $4.81B | $7.18B | 0.67 |
| 2025-12-31 | $4.92B | $7.25B | 0.68 |
| 2025-09-30 | $4.76B | $7.38B | 0.65 |
| 2025-06-30 | $4.81B | $7.56B | 0.64 |
| 2025-03-31 | $4.72B | $7.64B | 0.62 |
| 2024-12-31 | $4.73B | $7.67B | 0.62 |
| 2024-09-30 | $4.85B | $7.92B | 0.61 |
| 2024-06-30 | $5.56B | $7.87B | 0.71 |
| 2024-03-31 | $5.59B | $7.85B | 0.71 |
| 2023-12-31 | $5.69B | $7.87B | 0.72 |
| 2023-09-30 | $5.73B | $7.69B | 0.74 |
| 2023-06-30 | $6.35B | $7.87B | 0.81 |
| 2023-03-31 | $6.60B | $8.03B | 0.82 |
| 2022-12-31 | $6.75B | $7.38B | 0.91 |
| 2022-09-30 | $6.76B | $7.07B | 0.96 |
| 2022-06-30 | $7.02B | $7.17B | 0.98 |
| 2022-03-31 | $7.66B | $7.19B | 1.07 |
| 2021-12-31 | $7.86B | $7.14B | 1.10 |
| 2021-09-30 | $7.94B | $6.96B | 1.14 |
| 2021-06-30 | $4.50B | $4.24B | 1.06 |
| 2021-03-31 | $4.76B | $4.00B | 1.19 |
| 2020-12-31 | $4.23B | $3.74B | 1.13 |
| 2020-09-30 | $3.63B | $3.23B | 1.12 |
| 2020-06-30 | $3.67B | $2.97B | 1.24 |
| 2020-03-31 | $3.63B | $2.76B | 1.31 |
| 2019-12-31 | $3.73B | $2.81B | 1.32 |
| 2019-09-30 | $3.78B | $2.71B | 1.40 |
| 2019-06-30 | $3.69B | $2.71B | 1.36 |
| 2019-03-31 | $3.45B | $2.64B | 1.31 |
| 2018-12-31 | $3.39B | $2.59B | 1.31 |
| 2018-09-30 | $3.29B | $2.57B | 1.28 |
| 2018-06-30 | $3.44B | $2.52B | 1.37 |
| 2018-03-31 | $3.57B | $2.56B | 1.40 |
| 2017-12-31 | $3.59B | $2.50B | 1.43 |
| 2017-09-30 | $2.20B | $2.54B | 0.87 |
| 2017-06-30 | $2.17B | $2.44B | 0.89 |
| 2017-03-31 | $2.13B | $2.21B | 0.97 |
| 2016-12-31 | $2.12B | $2.15B | 0.99 |
| 2016-09-30 | $2.17B | $2.14B | 1.02 |
| 2016-06-30 | $2.11B | $2.09B | 1.01 |
| 2016-03-31 | $2.16B | $2.05B | 1.06 |
| 2015-12-31 | $2.06B | $2.11B | 0.97 |
| 2015-09-30 | $1.98B | $2.05B | 0.96 |
| 2015-06-30 | $1.96B | $2.12B | 0.93 |
| 2015-03-31 | $1.97B | $2.06B | 0.96 |
| 2014-12-31 | $2.09B | $2.04B | 1.02 |
| 2014-09-30 | $1.82B | $2.06B | 0.88 |
| 2014-06-30 | $1.88B | $2.06B | 0.92 |
| 2014-03-31 | $1.94B | $2.03B | 0.96 |
| 2013-12-31 | $1.95B | $1.99B | 0.98 |
| 2013-09-30 | $1.93B | $1.92B | 1.01 |
| 2013-06-30 | $1.95B | $1.86B | 1.05 |
| 2013-03-31 | $1.97B | $1.83B | 1.08 |
| 2012-12-31 | $1.96B | $1.94B | 1.01 |
| 2012-09-30 | $1.95B | $1.94B | 1.00 |
| 2012-06-30 | $1.92B | $1.89B | 1.02 |
| 2012-03-31 | $1.98B | $1.88B | 1.05 |
| 2011-12-31 | $2.01B | $1.84B | 1.09 |
| 2011-09-30 | $1.46B | $1.95B | 0.75 |
| 2011-06-30 | $1.64B | $1.96B | 0.84 |
| 2011-03-31 | $1.40B | $1.91B | 0.73 |
| 2010-12-31 | $1.28B | $1.93B | 0.67 |
| 2010-09-30 | $1.54B | $1.71B | 0.90 |
| 2010-06-30 | $1.50B | $1.64B | 0.91 |
| 2010-03-31 | $1.40B | $1.63B | 0.86 |
| 2009-12-31 | $1.43B | $1.63B | 0.88 |
| 2009-09-30 | $1.46B | $1.60B | 0.91 |
| 2009-06-30 | $1.37B | $1.57B | 0.87 |
| 2009-03-31 | $1.35B | $1.51B | 0.89 |
| 2008-12-31 | $1.36B | $1.57B | 0.87 |
| 2008-09-30 | $1.39B | $1.64B | 0.85 |
| 2008-06-30 | $1.42B | $1.66B | 0.86 |
| 2008-03-31 | $1.46B | $1.62B | 0.90 |
| 2007-12-31 | $1.37B | $1.58B | 0.87 |
| 2007-09-30 | $1.06B | $1.54B | 0.69 |
| 2007-06-30 | $1.04B | $1.50B | 0.69 |
| 2007-03-31 | $0.96B | $1.54B | 0.62 |
| 2006-12-31 | $0.93B | $1.58B | 0.59 |
| 2006-09-30 | $0.95B | $1.56B | 0.61 |
| 2006-06-30 | $0.94B | $1.60B | 0.58 |
| 2006-03-31 | $0.92B | $1.58B | 0.58 |
| 2005-12-31 | $1.04B | $1.65B | 0.63 |
| 2005-09-30 | $1.01B | $1.49B | 0.68 |
| 2005-06-30 | $1.04B | $1.46B | 0.71 |
| 2005-03-31 | $1.11B | $1.46B | 0.76 |
| 2004-12-31 | $1.12B | $1.46B | 0.76 |
| 2004-09-30 | $1.17B | $1.39B | 0.84 |
| 2004-06-30 | $1.19B | $1.37B | 0.87 |
| 2004-03-31 | $1.21B | $1.36B | 0.89 |
| 2003-12-31 | $1.26B | $1.35B | 0.93 |
| 2003-09-30 | $1.29B | $1.30B | 0.99 |
| 2003-06-30 | $1.48B | $1.29B | 1.15 |
| 2003-03-31 | $1.49B | $1.26B | 1.19 |
| 2002-12-31 | $1.57B | $1.25B | 1.26 |
| 2002-09-30 | $1.39B | $1.21B | 1.14 |
| 2002-06-30 | $1.49B | $1.22B | 1.21 |
| 2002-03-31 | $1.57B | $1.32B | 1.19 |
| 2001-12-31 | $1.61B | $1.36B | 1.18 |
| 2001-09-30 | $1.46B | $0.81B | 1.79 |
| 2001-06-30 | $1.50B | $0.77B | 1.94 |
| 2001-03-31 | $1.54B | $0.74B | 2.09 |
| 2000-12-31 | $1.46B | $0.73B | 2.00 |
| 2000-09-30 | $1.58B | $0.68B | 2.33 |
| 2000-06-30 | $1.12B | $0.67B | 1.66 |
| 2000-03-31 | $1.10B | $0.65B | 1.69 |
| 1999-12-31 | $1.16B | $0.55B | 2.11 |
| 1999-09-30 | $1.15B | $0.52B | 2.22 |
| 1999-06-30 | $1.25B | $0.40B | 3.11 |
| 1999-03-31 | $0.77B | $0.40B | 1.92 |
| 1998-12-31 | $0.79B | $0.40B | 1.97 |
| 1998-09-30 | $0.55B | $0.38B | 1.45 |
| 1998-06-30 | $0.54B | $0.39B | 1.37 |
| 1998-03-31 | $0.51B | $0.35B | 1.47 |
| 1997-12-31 | $0.50B | $0.33B | 1.53 |
| 1997-09-30 | $0.49B | $0.32B | 1.56 |
| 1997-06-30 | $0.49B | $0.32B | 1.52 |
| 1997-03-31 | $0.46B | $0.35B | 1.30 |
| 1996-12-31 | $0.46B | $0.37B | 1.25 |
| 1996-09-30 | $0.46B | $0.38B | 1.22 |
| 1996-06-30 | $0.47B | $0.37B | 1.29 |
| 1996-03-31 | $0.46B | $0.36B | 1.27 |
| 1995-12-31 | $0.44B | $0.37B | 1.19 |
| 1995-09-30 | $0.43B | $0.36B | 1.18 |
| 1995-06-30 | $0.35B | $0.44B | 0.79 |
| 1995-03-31 | $0.37B | $0.44B | 0.85 |
| 1994-12-31 | $0.35B | $0.45B | 0.78 |
| 1994-09-30 | $0.34B | $0.45B | 0.77 |
| 1994-06-30 | $0.30B | $0.49B | 0.62 |
| 1994-03-31 | $0.30B | $0.47B | 0.64 |
| 1993-12-31 | $0.29B | $0.48B | 0.61 |
| 1993-09-30 | $0.32B | $0.46B | 0.69 |
| 1993-06-30 | $0.34B | $0.46B | 0.75 |
| 1993-03-31 | $0.30B | $0.46B | 0.64 |
| 1992-12-31 | $0.28B | $0.47B | 0.58 |
| 1992-09-30 | $0.30B | $0.45B | 0.65 |
| 1992-06-30 | $0.31B | $0.44B | 0.71 |
| 1992-03-31 | $0.30B | $0.43B | 0.69 |
| 1991-12-31 | $0.28B | $0.42B | 0.66 |
| 1991-09-30 | $0.28B | $0.39B | 0.73 |
| 1991-06-30 | $0.28B | $0.37B | 0.76 |
| 1991-03-31 | $0.31B | $0.37B | 0.84 |
| 1990-12-31 | $0.31B | $0.37B | 0.83 |
| 1990-09-30 | $0.31B | $0.35B | 0.90 |
| 1990-06-30 | $0.29B | $0.36B | 0.81 |
| 1990-03-31 | $0.28B | $0.36B | 0.80 |
| 1989-12-31 | $0.29B | $0.35B | 0.84 |
| 1989-09-30 | $0.23B | $0.32B | 0.73 |
| 1989-06-30 | $0.22B | $0.31B | 0.71 |
| 1989-03-31 | $0.23B | $0.33B | 0.70 |
| 1988-12-31 | $0.21B | $0.33B | 0.62 |
| 1988-09-30 | $0.22B | $0.29B | 0.75 |
| 1988-06-30 | $0.24B | $0.29B | 0.83 |
| 1988-03-31 | $0.25B | $0.28B | 0.88 |
| 1987-12-31 | $0.25B | $0.29B | 0.89 |
| 1987-09-30 | $0.22B | $0.26B | 0.85 |
| 1987-06-30 | $0.23B | $0.26B | 0.91 |
| 1987-03-31 | $0.22B | $0.25B | 0.88 |
| 1986-12-31 | $0.22B | $0.24B | 0.90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.039B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |